Tag: monoclonal antibodies
Yet Another Alzheimer’s Drug
A third drug either FDA approved or showing clinical benefit for Alzheimer's disease confirms that the world of AD treatment has changed forever.
FDA Approves Leqembi for Alzheimer’s
FDA upgrades Leqembi for AD from accelerated to traditional approval based on latest clinical data.
Another Controversial Alzheimer’s Drug
A new treatment for Alzheimer's Disease is promising, but we're not there yet.
Crizanlizumab for Sickle Cell Crisis
Monoclonal antibodies to prevent sickle cell crises represents the promise and difficulties of high tech medical treatment.
Preventing Malaria: A Glimmer of Hope?
A recent clinical trial tested a new approach to malaria prevention involving monoclonal antibodies.